Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford University’s commitment to entrepreneurship has taken a major new step, with the opening of its new science enterprise hub, the Begbroke Innovation Accelerator.

Professor Ian Walmsley, Pro-Vice Chancellor of Oxford University officially opens the Begbroke Innovation Accelerator with Nicola Blackwood MP. Picture credit: David Tolley

Part-funded by the Oxford and Oxfordshire City Deal, the new building was officially opened on March 17th 2017 at Begbroke Science Park (BSP), by Nicola Blackwood MP, Minister for Public Health and Innovation.

An extension to Begbroke’s Centre for Innovation and Enterprise, the new multi-use building will help small and medium-sized science businesses to take their projects to market. The building which has had significant interest and is already 60 per cent occupied, will also provide facilities for researchers from the University developing new innovative products and technologies. The site’s primary focus will be on the advanced engineering sectors of automotive, nuclear materials, advanced materials, robotics, as well as in nano-medicine, pharmaceuticals, energy storage and supercomputing.

Read more

Similar stories

Oxford Innovation Society celebrates pioneering biomedical research and innovation

Last month the Oxford Innovation Society (OIS) hosted an event at Pembroke College which celebrated some of the pioneering translational research and innovation coming out of the University’s Medical Sciences Division.

Oxford spinout Optellum secures $14m funding to advance pioneering AI-powered lung cancer diagnosis technology

Optellum, a University of Oxford spinout that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round.

Oxford spinout MiroBio acquired by Gilead Sciences for $405m

The inflammatory diseases company’s rapid ascent and exit underscores the importance of friendships, partnerships and networks in innovation.

Oxford to receive £7 million to turn bright ideas into global opportunities

The University of Oxford has been awarded more than £7 million, the highest amount of funding given to organisations across the UK, in the latest round of UK Research and Innovation’s (UKRI) Impact Acceleration Account (IAA) funding - aimed at fueling the best, brightest and most disruptive ideas from UK research institutions.

Oxford expands the Cartography collaboration with Janssen

The University of Oxford announced today that it has expanded a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The agreement was facilitated by Johnson & Johnson Innovation

Oxford spin-out Optellum attains CE marking for its early lung cancer diagnosis AI technology

The contribution of individual features on clinical imaging scans to the performance of the LCP-CNN cancer risk prediction model developed in Oxford was investigated.